Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) currently has a “Sell” signals on Composite indicators by TrendSpotter. While the Short-Term Technical Indicators for the stock on 7-Day Average Directional Indicator shows “Sell” signal. 10 – 8 Day Moving Average Hilo Channel shows “Sell” signal. While 20-Day Moving Average VS Current Price shows “Sell” Signal.
Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) lost -5 Percent and closed its previous trading session at $1.71. The stock traded with the average Volume of 2.6 Million at the end of last session.
Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) has the Market Capitalization of 88.07 Million. The Stock has its 52-week High of $3.84 and 52-Week Low of $0.93 and it touched its 52-week high on 03/02/17 and 52-Week Low on 08/29/17.
The company reported its last earnings Actual EPS of $-0.14/share. While, the analyst predicted that the company could provide an EPS of $-0.21/share. Hence the difference between Predicted EPS and Actual EPS reported is $0.07/share which shows an Earnings Surprise of 33.3 Percent.
Several analysts are forecasting growth estimate of Infinity Pharmaceuticals, Inc. for the current quarter to be 45.7%. Their projections for the Next Quarter growth is -104.8 percent. While for the Next 5 years, the company could expect a growth of 89.63% per annum, whereas in the past Five years Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) showed a growth of 19.94 Percent per annum.
The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -18.4% where SMA50 and SMA200 are -16.64% and -10.33% respectively.
The company shows its Return on Assets (ROA) value of -59.8%. The Return on Equity (ROE) value stands at -85.6%. While it’s Return on Investment (ROI) value is -30.3%.
Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) currently has a Weekly Volatility of 7.33% percent while its Monthly Volatility is at 9.66% percent. While talking about Performance of the Stock, Infinity Pharmaceuticals, Inc. currently has a Weekly performance of -12.76%, monthly performance percentage is -32.41 percent, Quarterly performance is 29.55 percent, 6 months performance shows a percent value of -3.39% and Yearly Performance is 6.88 percent.
Infinity Pharmaceuticals, Inc. is an innovative cancer drug discovery and development company that is seeking to leverage its strength in small molecule drug technologies to discover, develop, and deliver to patients best-in-class medicines for the treatment of cancer and related conditions.